【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Uterine Fibroids 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Uterine Fibroids 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Uterine Fibroids Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Repros Therapeutics Inc. 34
Clinical Trial Overview of Repros Therapeutics Inc. 34
Neurocrine Biosciences, Inc. 36
Clinical Trial Overview of Neurocrine Biosciences, Inc. 36
AbbVie Inc. 37
Clinical Trial Overview of AbbVie Inc. 37
PregLem SA 38
Clinical Trial Overview of PregLem SA 38
Mediterranea Medica S.L. 39
Clinical Trial Overview of Mediterranea Medica S.L. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
HRA Pharma, SA 42
Clinical Trial Overview of HRA Pharma, SA 42
T-cell Technologies, Inc. 43
Clinical Trial Overview of T-cell Technologies, Inc. 43
Laboratorios Litaphar, S.A. 44
Clinical Trial Overview of Laboratorios Litaphar, S.A. 44
BioPro Pharmaceutical, Inc. 45
Clinical Trial Overview of BioPro Pharmaceutical, Inc. 45
Halt Medical, Inc. 46
Clinical Trial Overview of Halt Medical, Inc. 46
Bayer AG 47
Clinical Trial Overview of Bayer AG 47
Nippon Kayaku Co., Ltd. 48
Clinical Trial Overview of Nippon Kayaku Co., Ltd. 48
Actavis, Inc. 49
Clinical Trial Overview of Actavis, Inc. 49
GlaxoSmithKline plc 50
Clinical Trial Overview of GlaxoSmithKline plc 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
INC Research, LLC 52
Clinical Trial Overview of INC Research, LLC 52
Philips Healthcare 53
Clinical Trial Overview of Philips Healthcare 53
Clinical Trial Overview of Top Institutes / Government 54
Eunice Kennedy Shriver National Institute of Child Health and Human Development 54
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 54
National Institute of Environmental Health Sciences 55
Clinical Trial Overview of National Institute of Environmental Health Sciences 55
Imperial College London 56
Clinical Trial Overview of Imperial College London 56
Chinese University of Hong Kong 57
Clinical Trial Overview of Chinese University of Hong Kong 57
National Cancer Institute 58
Clinical Trial Overview of National Cancer Institute 58
University of Sao Paulo 59
Clinical Trial Overview of University of Sao Paulo 59
Northwestern University 60
Clinical Trial Overview of Northwestern University 60
Ullevaal University Hospital 61
Clinical Trial Overview of Ullevaal University Hospital 61
University of California, San Francisco 62
Clinical Trial Overview of University of California, San Francisco 62
The Cleveland Clinic 63
Clinical Trial Overview of The Cleveland Clinic 63
Taipei Veterans General Hospital 64
Clinical Trial Overview of Taipei Veterans General Hospital 64
Mayo Clinic 65
Clinical Trial Overview of Mayo Clinic 65
University of Mannheim 66
Clinical Trial Overview of University of Mannheim 66
Far Eastern Memorial Hospital 67
Clinical Trial Overview of Far Eastern Memorial Hospital 67
University of Oxford 68
Clinical Trial Overview of University of Oxford 68
National Center for Complementary and Alternative Medicine 69
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 69
VU University Medical Center 70
Clinical Trial Overview of VU University Medical Center 70
Catholic University of the Sacred Heart 71
Clinical Trial Overview of Catholic University of the Sacred Heart 71
University of California, Davis 72
Clinical Trial Overview of University of California, Davis 72
Assistance Publique – Hopitaux de Paris 73
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 73
Five Key Clinical Profiles 74
Appendix 130
Abbreviations 130
Definitions 130
Research Methodology 131
Secondary Research 131
About GlobalData 132
Contact Us 132
Disclaimer 132
Source 133
【レポート販売概要】
■ タイトル：Uterine Fibroids：グローバル臨床試験レビューH2, 2013■ 英文：Uterine Fibroids Global Clinical Trials Review, H2, 2013
■ 発行日：2013年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161603
■ 調査対象地域：グローバル
- 世界のフレキシブルディスプレイ市場動向（2012-2016）TechNavio's analysts forecast the Global Flexible Displays market to grow at a CAGR of 45.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high demand for flexible displays in smartphones and tablet computers. The Global Flexible Displays market has also been witnessing the rapid technological advancement. However, lack of technology standards c …
- がん胎児性抗原の世界市場分析：用途別（結腸直腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん）、セグメント予測Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools …
- スマートグリッド政策ハンドブック2013Smart Grid Policy Handbook 2013: Major Government Policies, Regulations and Incentives Summary "Smart Grid Policy Handbook 2013: Major Government Policies, Regulations and Incentives” is the latest policy report from GlobalData, the industry analysis specialists that offer comprehensive information on major policies governing the smart grid market in major countries. The report provides in-depth a …
- 保険詐欺検知の世界市場予測（～2024年）The exponential rise in the sophistication of cyber attacks insurance sector and substantial monetary losses due to these attacks will drive the overall insurance fraud detection market The global insurance fraud detection market size is expected to grow from USD 2.5 billion in 2019 to USD 7.9 billion by 2024, at a compound annual growth rate (CAGR) of 25.8% during the forecast period. Various fac …
- 米国のスパ市場2016-2020About the Spa Market in the US Owing to today’s hectic lifestyles, the need for de-stressing is gaining utmost importance. This factor, coupled with the growing demand for exclusive beauty services and treatments, is driving the spa market in the US. To address the growing demand for spa services across the country and to increase their profit margins, vendors are focusing more on expanding their …
- Reliance Industries Limited：石油・ガスバリューチェーン分析レポート2013Reliance Industries Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Reliance Industries Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Reliance Industries Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value c …
- 消化酵素サプリメントの世界市場About Digestive Enzyme SupplementsDigestive enzymes are substances produced by a human body that aid in digestion of food. In cases of individuals, where there are insufficient enzymes, digestive enzyme supplements are consumed to assist digestion. Technavio’s analysts forecast the global digestive enzyme supplements market to grow at a CAGR of 5.23% during the period 2017-2021. [Covered in this r …
- Faldaprevir and BI 207127 (Hepatitis C Virus)：市場予測と分析（～2022）Faldaprevir and BI 207127 (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by th …
- 3D磁気センサーの世界市場展望2017-20276According to Stratistics MRC, the Global 3D Magnetic Sensor Market is expected to grow at a CAGR of 19.7% during the forecast period. Some of the key factors influencing the market are growiing in automotive industry and unceasing growth in consumer electronics. However, Lengthy design phase increases time-to-market and falling average selling prices (ASPS) of sensor components affecting new marke …
- 世界の黒鉛市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of graphite, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing graphite production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: graphite prod …
- 分散型天然ガス電源の世界市場規模及び予測：技術別（天然ガス発電機、固定式燃料電池、マイクロタービン）、エンドユーザー別（住宅、ビル･機関、商業および産業）、セグメント予測The global distributed natural gas-fueled generation market is expected to reach USD 32.21 Billion by 2024, according to a new report by Grand View Research, Inc. Increasing government initiatives to promote the use of natural gas as a generator fuel especially in emerging markets of China, and India is expected to boost the global market. In addition, various benefits offered by DNGG, such as low …
- 特殊紙の世界市場：デコレーション紙、剥離ライナー紙、包装紙、印刷紙The specialty paper market has grown exponentially in the last few years and this trend is projected to continue. The market was valued at 24,239.57 KT in 2014. It is projected to grow at a CAGR of 6.59% from 2015 to reach 34,879.08 KT by 2020. The market is primarily driven by factors such as increasing disposable income, increasing specialty paper end-use application, and its easy availability. …
- Bis(2-カルボキシエチル)イソシアヌレートの世界市場Bis(2-carboxyethyl)isocyanurate (CAS 2904-40-7) Market Research Report 2014 presents comprehensive data on bis(2-carboxyethyl)isocyanurate markets globally and regionally (Europe, Asia, North America etc.) The report includes bis(2-carboxyethyl)isocyanurate description, covers its application areas and related patterns. It overviews bis(2-carboxyethyl)isocyanurate market, names bis(2-carboxyethyl) …
- 植物ベース肉の世界市場：種類別、地域別Global Plant-based Meat Market: About this market Technavio’s plant-based meat market analysis considers sales from plant-based beef, plant-based chicken, plant-based pork, and other types. Our study also finds the sales of plant-based meat in APAC, Europe, MEA, North America, and South America. In 2019, the plant-based beef segment had a significant market share, and this trend is expected to con …
- 事業提携・ライセンシング・投資・M&A動向（四半期別）：Q3 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
